NCT04234113 2026-03-27Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid TumorsSotio Biotech Inc.Phase 1 Terminated115 enrolled 43 charts
NCT04278144 2025-09-15A First-in-human Study Using BDC-1001 as a Single Agent and in Combination With Nivolumab in Advanced HER2-Expressing Solid TumorsBolt Biotherapeutics, Inc.Phase 1/2 Terminated175 enrolled
NCT04209465 2025-04-17MasterKey-01Black Diamond Therapeutics, Inc.Phase 1 Terminated91 enrolled 26 charts